Drug marketing exclusivity under United States and European Union law

Food and Drug Law Journal

Volumn 59, Issue 4, 2004, Pages

  Junod, Valerie ^a,b,c  

^a Junod Guyet Muhlstein and Levy ^*  (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c STANFORD LAW SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; DRUG APPROVAL; DRUG CONTROL; DRUG DESIGN; DRUG INDUSTRY; DRUG LEGISLATION; DRUG MARKETING; DRUG PROGRAM; DRUG RESEARCH; DRUG SAFETY; EUROPEAN UNION; FOOD AND DRUG ADMINISTRATION; LAW SUIT; LEGAL ASPECT; LEGAL LIABILITY; PATENT; REVIEW; UNITED STATES;

BIOPHARMACEUTICS; CLINICAL TRIALS; COMMERCE; DRUG APPROVAL; DRUG INDUSTRY; DRUGS, GENERIC; DRUGS, NON-PRESCRIPTION; ECONOMIC COMPETITION; EUROPEAN UNION; HUMANS; INVESTIGATIONAL NEW DRUG APPLICATION; LEGISLATION, DRUG; MARKETING OF HEALTH SERVICES; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 15444370003     PISSN: 1064590X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)